Craig Clark
Psychiatry · Nashville, TNNPI 1164529186
Payments from drug & device makers
What this record shows
This record is dominated by speaking fees: $25,173 of the $31,436 with a category attached, or 80.1%. Supernus Pharmaceuticals, Inc. accounts for 69.7% of it on its own, with 25 other manufacturers making up the rest. Reporting peaked in 2021 at $22,407 and has fallen 96.9% since, to $693 in 2025. Among psychiatry clinicians in TN with any reported payments, this total sits in the top 5% — high for the specialty, which is a reason to read the composition above rather than the number alone.
Across 304 payments — averaging $103.41 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.
- Supernus Pharmaceuticals, Inc.$22K
- Takeda Pharmaceuticals U.S.A., Inc.$7K
- AbbVie$506
- Corium, LLC$358
- Tris Pharma Inc$325
- Axsome Therapeutics, Inc.$267
- plus $1K from 20 others
What the payments were for
- Speaking & faculty fees$25,17380%
- Travel & lodging$1,2774%
- Food & beverage$4,94916%
- Education$370%
General payments by program year
Who reported the general payments
Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.
| Company | Payments | Total |
|---|---|---|
| Supernus Pharmaceuticals, Inc. | 110 | $21,901 |
| Takeda Pharmaceuticals U.S.A., Inc. | 19 | $6,623 |
| AbbVie(2 entities) | 41 | $506 |
| Corium, LLC | 21 | $358 |
| Tris Pharma Inc | 20 | $325 |
| Axsome Therapeutics, Inc. | 10 | $267 |
| Otsuka America Pharmaceutical, Inc. | 10 | $213 |
| Johnson & Johnson | 13 | $183 |
| Alkermes, Inc. | 9 | $168 |
| Sunovion Pharmaceuticals Inc. | 9 | $146 |
| Vanda Pharmaceuticals Inc. | 5 | $122 |
| Adlon Therapeutics L.p. | 6 | $102 |
| Jazz Pharmaceuticals Inc. | 4 | $71 |
| Lundbeck LLC | 5 | $67 |
| Brainsway USA Inc | 4 | $66 |
| Noven Therapeutics, LLC | 3 | $64 |
| ITI, Inc. (d/b/a Intra-cellular Therapies, Inc.) | 2 | $53 |
| Tempus AI, Inc | 2 | $42 |
| Vertical Pharmaceuticals, LLC | 3 | $38 |
| Ironshore Pharmaceuticals Inc. | 1 | $24 |
| Neuronetics, Inc. | 2 | $20 |
| Teva Pharmaceuticals USA, Inc. | 1 | $17 |
| Neos Therapeutics, LP | 1 | $17 |
| Avion Pharmaceuticals | 1 | $17 |
| Alfasigma USA, Inc. | 1 | $14 |
| Idorsia Pharmaceuticals US Inc | 1 | $12 |
What the payments were tied to
Products named in the reported payments. Only payments of $100 or more are attributed here — the typical reported payment nationally is a meal worth about $16, and listing those product-by-product would be noise.
How this compares
$31,436 in reported general payments places this provider in the 95th percentile of 503 psychiatry providers in Tennessee.
Most prescribed under Part D
| Drug | Claims | Cost to plans & patients |
|---|---|---|
| Vilazodone Hcl | 15 | $1,209 |
| Desvenlafaxine Succinate ErDesvenlafaxine Succinate | 15 | $839 |
| Lamotrigine | 46 | $369 |
| Aripiprazole | 33 | $334 |
| Prazosin Hcl | 13 | $215 |
| Clonazepam | 11 | $116 |
| Trazodone Hcl | 23 | $113 |
| Sertraline Hcl | 15 | $98 |
| Alprazolam | 12 | $74 |
| Fluoxetine Hcl | 13 | $73 |
Paid to pharmacies, not to this prescriber.
Other psychiatry in Nashville
- Rakesh AminNashville$3M
- Robert JamiesonNashville$141K
- Michelle CochranNashville$74K
- Amanda Sparks-BushnellNashville$66K
- Joseph SharpeNashville$29K
- Colleen FriddellNashville$23K
- Jane WeinbergNashville$22K
- Esiri EsinNashville$18K
- Tianlai TangNashville$11K
- Marianne RaynesNashville$11K
Where these figures come from
- Payments: CMS Open Payments, program years 2019–2025 (publication P06302026_06032026).
- Identity: NPPES NPI Registry, July 2026.